Bioinnovation has the potential to power your business ambition. And we are uniquely placed – with world-class expertise and facilities – to help deliver tangible, valuable commercial advantage.

We innovate at the exciting intersection of biology, engineering and advanced computation… to deliver breakthrough products and services with world-changing significance. Ours is a comprehensive approach founded on three core capabilities – Biostrategy, Biomeasurement and Biomanufacture. 

Biostrategy, Biomeasurement and Biomanufacture

Getting to market as the world transforms

Now more than ever, your route to market must navigate a complex, shifting global landscape. As risks arise, so do the potential rewards. Bioinnovation has the rare capacity to provide clarity and momentum in critical areas of opportunity, such as healthcare, agriculture and climate change. 

Ideas are the easier part; making them a reality is harder. The truth is, you require more than good technology to deliver positive change in a commercial context. To get to market, you need robust, realistic strategies. We can help you develop them because we understand the tools (biotechnology), the rules (governance models) and the interests (economic models) involved. Aligning all three is the secret to business success in Bioinnovation. 

Gaining insight with better information

Bioinnovation relies absolutely on Biomeasurement. It is the bedrock that enables control and optimization. But biological systems are extremely complex, span a huge scale range from km to nm and are incredibly difficult to measure. Success relies on seamless integration across numerous disciplines at which we are adept – including wetware, hardware and software. 

Our unique blend of abilities helps you bring new measurement and diagnosis products to market or integrate new measurement tools into your process and catalyze productivity gains. We understand and develop innovative sensors and cutting-edge data analysis. We’re able to bring together molecular biology, assay development, physics, electronics and AI to achieve the most complex measurements. And we package them for you in robust, easy-to-use, cost-effective solutions that comply with stringent regulatory requirements, including cGMP and medical device quality systems. 

Scaling up and delivering at viable cost

Researchers are continually discovering new ways to apply biology in their pursuit of breakthrough innovation. The real challenge is moving complex processes from the lab to high-volume manufacture at a cost that delivers business viability. Experience tells us that successful scale up demands optimization and invention across all disciplines – including biology, hardware, usability and control systems – plus rigorous regulatory compliance. 

We can help you optimize processes and develop the custom equipment you need to deliver at commercial cost and scale. We work seamlessly across biology, process optimization and equipment design to enable the successful manufacture and delivery of your product or advanced medical therapy. 

Talk to us about world-changing science

Our experience 

Proven in biodesign 

Our proven biodesign capability has grown organically from our long history in healthcare and life sciences. Few if any of our peers can match our holistic approach which adds biodesign to the complementary disciplines of engineering and computation. This unique breadth of expertise offers significant advantages that speed and ease your path to biomanufacture. 

Antha expertise 

Antha is a programming language for biology. It describes and executes complex workflows, driving massive productivity gains during biodesign. We are long-term partners with Synthace and use Antha in our labs. We can help you discover the power of Antha to unlock your science and gather the data you need without limits.    

Meet the core team

"Bioinnovation has the potential to reshape the global economy and transform every sector, in profound ways. Working here in Boston with our ambitious clients to realize their ideas and discoveries is tremendously rewarding." 
Mike Dunkley

"Biology knows no bounds and follows different rules to typical engineering tools and materials."
Ellen Simmons

"Providing unique solutions that take advantage of the breadth and depth of our collective knowledge is immensely fulfilling. I am very excited to be a part of our Boston-based bioinnovation team that expands our local and global expertise to include mammalian cell biology. This positions us to meet the diverse challenges our clients face in the ever-growing space where biological needs intersect with the computational and engineering arenas."
Karen Weisinger

“What excites me most is that bioinnovation will affect so many different industries – from the obvious ones like healthcare and agriculture to the more surprising like data storage and plastics.”  James Hallinan

"Our clients are diverse, the science they are trying to deliver is novel. Every project brings the opportunity to gain a new understanding." 
 Ian Taylor

Tech, tools & facilities

Synthetic biology lab


ケンブリッジ本社の微生物学ラボでは、微生物の遺伝子組み換えを実施することができます。当社の施設は、病原菌株を扱うためのバイオセーフティ・レベル 2であり、社内ライブラリにより、迅速なモジュール式 DNA の設計と組み立てが可能です。特にヘルスケアおよび産業用バイオテクノロジーの可能性に向け、バイオ・センサーとして機能する微生物に注力しています。

Life Science Labs






Case studies


CATALOG DNA data encoding machine

2020年 05月 11日

Enabling the world's first DNA-based platform for massive data storage.

  • バイオイノベーション

Better Origin insect larvae rearing

2017年 11月 25日

Harnessing the science of synthetic biology and best-in-class automation to turn organic waste into high-protein fish food.

  • バイオイノベーション
  • 機械工学
  • ロボット工学

Biology-based contaminant monitoring

2017年 11月 23日

Developing biology-based sensors as a cost effective, long-term solution for monitoring environmental public health risks.

  • バイオイノベーション
  • 工業デザイン
  • 製品の実現
  • センシング

News & insights


Cambridge Consultants announces its collaboration with MedTech Innovator, a world-leading non-profit start-up accelerator

2021年 07月 13日

Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices.

  • バイオイノベーション
  • デジタルヘルス
  • イノベーション マネジメント
  • 製品の実現
  • サステナビリティ


2021年 05月 18日


  • バイオイノベーション

Flowfect™ Tx Revealed

2020年 10月 28日

Cambridge Consultants & Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.

  • バイオイノベーション


2018年 03月 27日


  • バイオイノベーション
  • イノベーション マネジメント
  • 製品の実現
  • 戦略的 アドバイス